FONAR Co. (NASDAQ:FONR - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 19,000 shares, an increase of 45.0% from the February 28th total of 13,100 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average trading volume of 13,000 shares, the days-to-cover ratio is presently 1.5 days.
Institutional Trading of FONAR
Several hedge funds and other institutional investors have recently bought and sold shares of FONR. Money Concepts Capital Corp boosted its holdings in shares of FONAR by 5.9% during the fourth quarter. Money Concepts Capital Corp now owns 401,577 shares of the medical equipment provider's stock worth $6,080,000 after purchasing an additional 22,245 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in FONAR by 0.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock worth $5,703,000 after buying an additional 2,149 shares during the period. Peapod Lane Capital LLC acquired a new stake in FONAR in the 4th quarter worth about $2,159,000. Truffle Hound Capital LLC purchased a new stake in FONAR in the 4th quarter valued at about $1,363,000. Finally, Bridgeway Capital Management LLC increased its stake in shares of FONAR by 1.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock valued at $1,212,000 after acquiring an additional 945 shares during the last quarter. 50.64% of the stock is owned by hedge funds and other institutional investors.
FONAR Trading Up 1.9 %
Shares of NASDAQ:FONR traded up $0.26 on Thursday, hitting $13.80. The company had a trading volume of 4,442 shares, compared to its average volume of 16,405. The company has a market cap of $85.60 million, a PE ratio of 12.00 and a beta of 1.27. The business has a 50 day moving average of $14.82 and a 200 day moving average of $15.39. FONAR has a 52-week low of $13.27 and a 52-week high of $20.18.
FONAR (NASDAQ:FONR - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The medical equipment provider reported $0.29 earnings per share (EPS) for the quarter. The company had revenue of $24.95 million for the quarter. FONAR had a net margin of 7.68% and a return on equity of 4.94%.
About FONAR
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Further Reading
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.